Previous Section
Clinical Trials
38. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
- Author
- Maluf FC; Leiser AL; Aghajanian C; Sabbatini P; Pezzulli S; Chi DS; Wolf JK; Levenback C; Loh E; Spriggs DR;
- Institution
- Developmental Chemotherapy Service and Gynecologic Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.
- Journal
- Int J Gynecol Cancer. 2006 May-Jun;16(3):1165-71.
- Abstract URL
- Click here to view abstract
39. Pemetrexed (Alimta, LY231514) demonstrates clinical activity in chemonaive patients with cervical cancer in a phase II single-agent trial.
- Author
- Goedhals L; van Wiyk AL; Smith BL; Fourie SJ;
- Institution
- Department of Oncotherapy, National Hospital, Private Bay, Bloemfontein X20598, South Africa. goedhall@doh.ofs.gov.za
- Journal
- Int J Gynecol Cancer. 2006 May-Jun;16(3):1172-8.
- Abstract URL
- Click here to view abstract
40. Randomized phase II study of immunomodulator Z-100 in patients with stage IIIB cervical cancer with radiation therapy.
- Author
- Noda K; Ohashi Y; Okada H; Ogita S; Ozaki M; Kikuchi Y; Takegawa Y; Niibe H; Fujii S; Horiuchi J; Morita K; Hashimoto S; Fujiwara K;
- Institution
- Kinki University, Japan.
- Journal
- Jpn J Clin Oncol. 2006 Sep;36(9):570-7. Epub 2006 Aug 22.
- Abstract URL
- Click here to view abstract
41. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
- Author
- Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
- Institution
- Department of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria. elfriede.greimel@meduni-graz.at
- Journal
- Cancer. 2006 Oct 15;107(8):1812-22.
- Abstract URL
- Click here to view abstract
